SCHEMBL4965313

SCHEMBL4965313

CCn1ccc(C2CCCC2)c1C(N)=O

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
SYK P43405 2/20 0.33
FASN P49327 2/20 0.33
GRM2 Q14416 1/20 0.33
PTGDR2 Q9Y5Y4 3/20 0.33
CYP2C9 P11712 1/20 0.33
HRH4 Q9H3N8 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
HASPIN Q8TF76 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15559211 0.70 KDM4E (0.32) KMT2AKDM4EMEN1MAPTCYP2C9
SCHEMBL1607925 0.66 SRD5A2 (0.39) KMT2AKDM4EMAPT
SCHEMBL5599182 0.63 KDM4E (0.44) KMT2AKDM4EMEN1MAPTPTGDR2
SCHEMBL161226 0.61 KDM4E (0.50) KMT2AKDM4EMEN1MAPTPTGDR2
SCHEMBL29839614 0.61 HSP90AA1 (0.34)
SCHEMBL6921914 0.61 KDM4E (0.43) KMT2AKDM4EMEN1MAPTPTGDR2
SCHEMBL4359674 0.60 KDM4E (0.45) KMT2AKDM4EMEN1MAPT
SCHEMBL29339016 0.60 KMT2A (0.35) KMT2AKDM4EMEN1
SCHEMBL15558595 0.60 RBP4 (0.33)
SCHEMBL307050 0.60 KDM4E (0.53) KMT2AKDM4EMEN1MAPTPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896454-A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR -SECRETASE MODULATION Wyeth a Corporation of the State of Delaware (US) 2008-03-12 EP claimed
WO-2007005366-A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION WYETH (US) 2007-01-11 WO claimed